Literature DB >> 22908849

Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts.

Katja Ihlefeld1, Ralf Frederik Claas, Alexander Koch, Josef M Pfeilschifter, Dagmar Meyer Zu Heringdorf.   

Abstract

Embryonic fibroblasts from S1P (sphingosine-1-phosphate) lyase-deficient mice [Sgpl1-/- MEFs (mouse embryonic fibroblasts)] are characterized by intracellular accumulation of S1P, elevated cytosolic [Ca2+]i and enhanced Ca2+ storage. Since S1P, produced by sphingosine kinase 2 in the nucleus of MCF-7 cells, inhibited HDACs (histone deacetylases) [Hait, Allegood, Maceyka, Strub, Harikumar, Singh, Luo, Marmorstein, Kordula, Milstein et al. (2009) Science 325, 1254-1257], in the present study we analysed whether S1P accumulated in the nuclei of S1P lyase-deficient MEFs and caused HDAC inhibition. Interestingly, nuclear concentrations of S1P were disproportionally elevated in Sgpl1-/- MEFs. HDAC activity was reduced, acetylation of histone 3-Lys9 was increased and the HDAC-regulated gene p21 cyclin-dependent kinase inhibitor was up-regulated in these cells. Furthermore, the expression of HDAC1 and HDAC3 was reduced in Sgpl1-/- MEFs. In wild-type MEFs, acetylation of histone 3-Lys9 was increased by the S1P lyase inhibitor 4-deoxypyridoxine. The non-specific HDAC inhibitor trichostatin A elevated basal [Ca2+]i and enhanced Ca2+ storage, whereas the HDAC1/2/3 inhibitor MGCD0103 elevated basal [Ca2+]i without influence on Ca2+ storage in wild-type MEFs. Overexpression of HDAC1 or HDAC2 reduced the elevated basal [Ca2+]i in Sgpl1-/- MEFs. Taken together, S1P lyase-deficiency was associated with elevated nuclear S1P levels, reduced HDAC activity and down-regulation of HDAC isoenzymes. The decreased HDAC activity in turn contributed to the dysregulation of Ca2+ homoeostasis, particularly to the elevated basal [Ca2+]i, in Sgpl1-/- MEFs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908849     DOI: 10.1042/BJ20120811

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

Review 1.  Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.

Authors:  Gregory T Kunkel; Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  Nat Rev Drug Discov       Date:  2013-08-19       Impact factor: 84.694

Review 2.  Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease.

Authors:  Julie D Saba
Journal:  J Lipid Res       Date:  2019-01-11       Impact factor: 5.922

3.  Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression.

Authors:  Ana Olivera; Yoshiaki Kitamura; Laurel D Wright; Maria L Allende; Weiping Chen; Tomomi Kaneko-Goto; Yoshihiro Yoshihara; Richard L Proia; Juan Rivera
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

4.  Upregulation of ABC transporters contributes to chemoresistance of sphingosine 1-phosphate lyase-deficient fibroblasts.

Authors:  Katja Ihlefeld; Hans Vienken; Ralf Frederik Claas; Kira Blankenbach; Agnes Rudowski; Michael ter Braak; Alexander Koch; Paul P Van Veldhoven; Josef Pfeilschifter; Dagmar Meyer zu Heringdorf
Journal:  J Lipid Res       Date:  2014-11-10       Impact factor: 5.922

Review 5.  Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase.

Authors:  David L Ebenezer; Panfeng Fu; Vidyani Suryadevara; Yutong Zhao; Viswanathan Natarajan
Journal:  Adv Biol Regul       Date:  2016-09-29

6.  Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein.

Authors:  Ilker Karaca; Irfan Y Tamboli; Konstantin Glebov; Josefine Richter; Lisa H Fell; Marcus O Grimm; Viola J Haupenthal; Tobias Hartmann; Markus H Gräler; Gerhild van Echten-Deckert; Jochen Walter
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

Review 7.  Sphingolipids: regulators of crosstalk between apoptosis and autophagy.

Authors:  Megan M Young; Mark Kester; Hong-Gang Wang
Journal:  J Lipid Res       Date:  2012-11-13       Impact factor: 5.922

Review 8.  Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.

Authors:  Panfeng Fu; David L Ebenezer; Alison W Ha; Vidyani Suryadevara; Anantha Harijith; Viswanathan Natarajan
Journal:  J Cell Biochem       Date:  2018-05-08       Impact factor: 4.429

Review 9.  The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.

Authors:  Masayuki Nagahashi; Kizuki Yuza; Yuki Hirose; Masato Nakajima; Rajesh Ramanathan; Nitai C Hait; Phillip B Hylemon; Huiping Zhou; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Lipid Res       Date:  2016-07-26       Impact factor: 5.922

Review 10.  Sphingolipid metabolites in inflammatory disease.

Authors:  Michael Maceyka; Sarah Spiegel
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.